Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.09.13.460076: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IACUC: In vivo experiments and vaccination: Vaccination experiments have been performed according to ethical guidelines, under a protocol approved by the Grenoble Ethical Committee for Animal Experimentation and the French Ministry of Higher Education and Researcher (reference number: APAFIS#27765-2020102114206782 v2). Sex as a biological variable 5-week-old female Balb/c mice were purchased from Janvier (Le Genestet St. Isle, France). Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources EXPI293 cells grown in EXPI293 expression medium were transiently transfected with … SciScore for 10.1101/2021.09.13.460076: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IACUC: In vivo experiments and vaccination: Vaccination experiments have been performed according to ethical guidelines, under a protocol approved by the Grenoble Ethical Committee for Animal Experimentation and the French Ministry of Higher Education and Researcher (reference number: APAFIS#27765-2020102114206782 v2). Sex as a biological variable 5-week-old female Balb/c mice were purchased from Janvier (Le Genestet St. Isle, France). Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources EXPI293 cells grown in EXPI293 expression medium were transiently transfected with the vector according to the manufacturer’s protocol (Thermo Fisher Scientific). EXPI293suggested: RRID:CVCL_D615)Briefly, gag/pol and luciferase plasmids were co-transfected with a SARS-CoV-2 spike plasmid with a C-term deletion of 18aa at 1/0,4/1 ratio on adherent HEK293T cells. HEK293Tsuggested: CCLV Cat# CCLV-RIE 1018, RRID:CVCL_0063)Before use, supernatants were tittered using HeLa ACE-2 cells to determine the appropriate dilution of pseudovirus necessary to obtain about 150 000 RLU per well in a 48 well-plate. HeLa ACE-2suggested: NoneNeutralization assay (mAb): Serial 3-fold dilutions starting from 1/10 dilution (serum), or 6µg/mL (known bNAbs) were let in contact with the pseudoviruses for 1h at 37°C in 96-w white plates (Greiner #675083), before addition of HeLa ACE2 cells. HeLa ACE2suggested: NoneExperimental Models: Organisms/Strains Sentences Resources 5-week-old female Balb/c mice were purchased from Janvier (Le Genestet St. Isle, France). Balb/csuggested: RRID:IMSR_ORNL:BALB/cRl)Recombinant DNA Sentences Resources Synthetic DNA (Genscript) was cloned in the pACEBac1 using the restriction sites BamHI and HindIII. pACEBac1suggested: RRID:Addgene_109156)RBD purification: The following reagent was produced under HHSN272201400008C and obtained through BEI Resources, NIAID, NIH: Vector pCAGGS Containing the SARS-Related Coronavirus 2, Wuhan-Hu-1 Spike Glycoprotein Receptor Binding Domain (RBD), NR-52309. pCAGGSsuggested: RRID:Addgene_18926)Software and Algorithms Sentences Resources Automated data collection was performed with SerialEM, acquiring one image per hole, in counting mode. SerialEMsuggested: (SerialEM, RRID:SCR_017293)Image processing and cryo-EM structure refinement: Movie drift correction was performed with Motioncor2 37 using frames from 2 to 40. Motioncor2suggested: (MotionCor2, RRID:SCR_016499)CTF determination was performed with Relion 3.1.2 (Scheres 2012). Relionsuggested: (RELION, RRID:SCR_016274)Statistical analyses: For ELISA and neutralization assays, IC50 were deduced from crude data after normalization using GraphPad Prism “log(inhibitor) vs normalized response” function. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
